SARS-CoV-2 Neutralizing Antibody kit
The Goldsite SARS-CoV-2 neutralizing antibody kit supports assessment of neutralizing antibody responses, positioned in manufacturer materials for COVID-19 vaccine efficacy monitoring and serology programs. Goldsite offers qualitative detection solutions with colloidal gold and immunofluorescence method options; catalog examples include CG124001 (colloidal gold) and GT124025 (immunofluorescence) neutralizing antibody kits. Sample types listed are whole blood, serum, and plasma. The colloidal gold pathway is described as not requiring an instrument, while buffer is required per kit design. Serology sites in Pakistani hospitals and research labs may use these kits where neutralizing antibody screening aligns with study protocols or public health surveys. Follow the IFU for specimen volume, incubation, and qualitative result criteria. Do not use beyond intended populations defined in the insert. Available through Zymotic Diagnostics International within the Goldsite COVID-19 serology range.




